Biologics Effectiveness and Safety (BEST) Initiative: Development of New and Innovative Methods for Automated Reporting for CBER-Regulated Products 2
ID: FDA-18-223-SOL-1196210 • Type: Solicitation
• Match:
100%
Opportunity Assistant
Loading
Overview
Response Deadline
July 31, 2018, 3:00 p.m. EDT
Past Due
Posted
July 24, 2018, 11:35 a.m. EDT
Set Aside
None
NAICS
Place of Performance
Contractors facility
USA
Source
Current SBA Size Standard
$40 Million
Pricing
Multiple Types Common
Est. Level of Competition
Average
Signs of Shaping
The solicitation is open for 7 days, below average for the FDA Office of Acquisition and Grant Services.
On 7/24/18 FDA Office of Acquisition and Grant Services issued Solicitation FDA-18-223-SOL-1196210 for Biologics Effectiveness and Safety (BEST) Initiative: Development of New and Innovative Methods for Automated Reporting for CBER-Regulated Products due 7/31/18.
The opportunity was issued full & open with NAICS 518210 and PSC B.
Primary Contact
Documents
Posted documents for Solicitation FDA-18-223-SOL-1196210
Question & Answer
The AI Q&A Assistant has moved to the bottom right of the page
Opportunity Lifecycle
Procurement notices related to Solicitation FDA-18-223-SOL-1196210
Award Notifications
Agency published notification of awards for Solicitation FDA-18-223-SOL-1196210
IDV Awards
Indefinite delivery vehicles awarded through Solicitation FDA-18-223-SOL-1196210
Contract Awards
Prime contracts awarded through Solicitation FDA-18-223-SOL-1196210
Incumbent or Similar Awards
Potential Bidders and Partners
Awardees that have won contracts similar to Solicitation FDA-18-223-SOL-1196210
Similar Active Opportunities
Open contract opportunities similar to Solicitation FDA-18-223-SOL-1196210
Additional Details
Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > FOOD AND DRUG ADMINISTRATION > Office of Acquisitions and Grants Services - Jefferson
Source Organization Code
2fdeafafa5da7b0cc4ba6b30084d5d18
Last Updated
Oct. 11, 2018
Last Updated By
PI33_DR_IAE_51681
Archive Date
Oct. 11, 2018